Active Ingredients (In Each Extended-Release Bi-Layer Tablet)
Dextromethorphan HBr 30 mg
Guaifenesin 600 mg
The following Structured Product Label (SPL) was submitted to the FDA by Navajo Manufacturing Company Inc. for the product Mucinex Dm (NDC 67751-171). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredients (in each extended-release bi-layer tablet), purposes, uses, do not use, ask a doctor before use if you have, when using this product, stop use and ask a doctor if, if pregnant or breast-feeding,, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Dextromethorphan HBr 30 mg
Guaifenesin 600 mg
Cough suppressant
Expectorant
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
carbomer homopolymer type B; D&C yellow #10 aluminum lake; hypromellose, USP; magnesium stearate, NF; microcrystalline cellulose, NF; sodium starch glycolate, NF
1-866-MUCINEX (1-866-682-4639) You may also report side effects to this phone number.
* Please review the disclaimer below.